Literature DB >> 6532375

Morphometric and biochemical analysis of adrenal medullary hyperplasia induced by nicotine in rats.

U A Boelsterli, L M Cruz-Orive, G Zbinden.   

Abstract

The administration of nicotine (1 and 4 mg/kg/day, subcutaneously for up to 6 weeks) to male Sprague-Dawley rats first induced a time-and dose-dependent increase in catecholamine (CA) synthesis. This was followed by an increase in endogenous CA levels and in total volume and number of chromaffin cells, as measured by stereological methods on serially sectioned adrenal glands. Thus, continued stimulation of the sympathoadrenal system generated an increase in biosynthetic enzyme activity, and subsequently adrenal medullary hypertrophy and hyperplasia developed as an adaptive reaction. The proposed model is useful for quantifying both biochemically and morphometrically early adrenal changes long before irreversible pathologic alterations are manifested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6532375     DOI: 10.1007/bf00349082

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  15 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  Nodular hyperplasia and increase of noradrenaline content in the adrenal medulla of nicotine-treated rats.

Authors:  O ERANKO
Journal:  Acta Pathol Microbiol Scand       Date:  1955

3.  Estimation of the volumes of the cortex and medulla from adrenal sections.

Authors:  O ERANKO
Journal:  Ann Med Exp Biol Fenn       Date:  1954

4.  Effect of chronic administration of nicotine on the concentrations of adrenal enzymes involved in the synthesis and metabolism of adrenaline.

Authors:  B Bhagat; M W Rana
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

5.  Elevation of adrenal tyrosine hydroxylase and phenylethanolamine-N-methyl transferase by repeated immobilization of rats.

Authors:  R Kvetnansky; V K Weise; I J Kopin
Journal:  Endocrinology       Date:  1970-10       Impact factor: 4.736

6.  3,4-dihydroxyphenylethylamine beta-hydroxylase. Physical properties, copper content, and role of copper in the catalytic acttivity.

Authors:  S Friedman; S Kaufman
Journal:  J Biol Chem       Date:  1965-12       Impact factor: 5.157

7.  Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography.

Authors:  L J Felice; J D Felice; P T Kissinger
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

8.  Effect of stimulation on the levels of tyrosine hydroxylase, dopamine beta-hydroxylase, and catecholamines in intact and denervated rat adrenal glands.

Authors:  R L Patrick; N Kirshner
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

9.  A sensitive enzymatic assay for dopamine- -hydroxylase.

Authors:  P B Molinoff; R Weinshilboum; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1971-09       Impact factor: 4.030

10.  Secretion from the cortex-free bovine adrenal medulla.

Authors:  F H Schneider
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

View more
  3 in total

1.  Biochemical and morphological changes of the rat adrenal medulla induced by peroral xylitol.

Authors:  K K Makinen; M M Hamalainen
Journal:  Arch Toxicol       Date:  1986-10       Impact factor: 5.153

2.  Early biochemical and morphological changes of the rat adrenal medulla induced by xylitol.

Authors:  U A Boelsterli; G Zbinden
Journal:  Arch Toxicol       Date:  1985-04       Impact factor: 5.153

3.  Reduced toxicological activity of cigarette smoke by the addition of ammonia magnesium phosphate to the paper of an electrically heated cigarette: subchronic inhalation toxicology.

Authors:  O Moennikes; P M Vanscheeuwijck; B Friedrichs; E Anskeit; G J Patskan
Journal:  Inhal Toxicol       Date:  2008-05       Impact factor: 2.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.